Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile

NCT05593042 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

551

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Vaccines

Interventions

BIOLOGICAL: CoronaVac®
BIOLOGICAL: Omicron Vaccine
BIOLOGICAL: Trivalent Vaccine

Sponsor

Pontificia Universidad Catolica de Chile

Collaborators

[object Object]